UNSPSC 51111754: Mitonafide

This classification denotes an intercalating agent with the molecular formula C16H15N3O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 06Q0V17SI9, chemically known as 2-((dimethylamino)ethyl)-2,3-dihydro-5-nitro-2-azaphenalen-1,3-dion but generally known as mitonafide, which bears US NIH Compound Identifier 41202. European Medicines Agency schedules Mitonafide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09007MIG.

UNSPSC 51111754 Mitonafide is a Commodity code under which state and local governments procure pharmaceutical products, medical supplies, and related health-system commodities to support public health initiatives, emergency response, and government employee health benefits. Recent solicitations show state and local agencies buying naloxone and drug deactivation systems for community health programs, medical and first aid supplies for fire departments, generic pharmaceuticals and over-the-counter products through multistate cooperative purchasing vehicles, and exploring direct-to-manufacturer prescription fulfillment arrangements to improve cost management and supply-chain efficiency. The issuing bodies include county health departments, city fire and rescue divisions, state health and human services commissions, and multistate cooperative purchasing alliances administering contracts across multiple states and participating jurisdictions. Procurement mechanisms range from traditional competitive bids (IFB) and requests for proposals (RFP) to exploratory requests for information (RFI) used to gather vendor capability data before formal solicitation.

Recent activity spans Florida, Texas, Minnesota, and Oregon, with particular concentration in multistate cooperative purchasing structures serving multiple jurisdictions simultaneously. Seminole County, Florida issued IFB 60459723LAS in June 2026 to procure 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries and a two-year initial term plus one-year renewal option, due July 26, 2023. The City of Tampa released ITB 26P00145 in March 2026 for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, designated as a sheltered market opportunity for certified Small Local Business Enterprises with a 5% bid discount capped at $10,000 and an estimated contract value of $700,000.00. Minnesota's multistate cooperative purchasing alliance (MMCAP) administered by the Minnesota Department of Administration issued RFP S1070000015802 in January 2026 for generic multi-source pharmaceuticals and OTC products distributed across state and local facilities including Oregon, with proposals due March 26, 2026 and contract effectiveness July 1, 2026. The Texas Health and Human Services Commission posted RFI HHS0017013 in April 2026 to gather market intelligence on direct-to-manufacturer prescription program capabilities, reflecting emerging state interest in alternative supply-chain models outside traditional pharmacy benefit manager and group purchasing organization arrangements.